Bank Of America Corp Neuro Metrix, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$1.36 - $22.72 $12,718 - $212,477	-9,352 Reduced 99.81%	18 $0
Q3 2022 Nov 14, 2022	SELL	$2.97 - $23.6 $61,716 - $490,408	-20,780 Reduced 68.92%	9,370 $26,000
Q2 2022 Aug 12, 2022	BUY	$2.81 - $5.5 $84,019 - $164,450	29,900 Added 11960.0%	30,150 $110,000
Q1 2022 May 16, 2022	BUY	$3.42 - $6.37 $855 - $1,592	250 New	250 $1,000
Q3 2021 Nov 15, 2021	SELL	$3.23 - $24.73 $106 - $816	-33 Closed	0 $0
Q2 2021 Sep 13, 2021	BUY	$2.72 - $3.8 $89 - $125	33 New	33 $0

320

Ticker NURO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,757,230
Market Cap $31.3M
Description
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.